Fig. 3: Salubrinal improved obesity-induced hepatic steatosis. | Cell Death & Disease

Fig. 3: Salubrinal improved obesity-induced hepatic steatosis.

From: Phosphorylation of eIF2α signaling pathway attenuates obesity-induced non-alcoholic fatty liver disease in an ER stress and autophagy-dependent manner

Fig. 3

a Serum triglyceride level. b Serum total cholesterol level. c Representative H&E and oil red O staining images showing salubrinal effect in hepatic steatosis (200×; scale bar = 100 μm; all graphics were in a blinded fashion). d The number of hepatic adipocytes. e The average area of hepatic adipocyte. f Oil red area. g Liver weight. The asterisks (*, **, and ***) represent P < 0.05, P < 0.01, and P < 0.001, respectively. N.s., not significant.

Back to article page